Zhu, L., Zou, J., Zhao, Y., Jiang, X., Wang, Y., Wang, X., & Chen, B. (2018). ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway. J Exp Clin Cancer Res.
Dyfyniad Arddull ChicagoZhu, Linlin, Jiao Zou, Yuanyin Zhao, Xiaomei Jiang, Yang Wang, Xiangwei Wang, and Bin Chen. "ER-α36 Mediates Cisplatin Resistance in Breast Cancer Cells Through EGFR/HER-2/ERK Signaling Pathway." J Exp Clin Cancer Res 2018.
Dyfyniad MLAZhu, Linlin, et al. "ER-α36 Mediates Cisplatin Resistance in Breast Cancer Cells Through EGFR/HER-2/ERK Signaling Pathway." J Exp Clin Cancer Res 2018.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.